Board Meeting14 May 2026, 03:20 pm
Ganga Pharma Board Meeting on May 21 to Approve Audited Results
AI Summary
Ganga Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the Audited Financial Results for the half year and financial year ended March 31, 2026. In compliance with SEBI regulations, the trading window for dealing in the company's securities has been closed from April 1, 2026, and will reopen 48 hours after the results are declared.
Key Highlights
- Board meeting scheduled for May 21, 2026, to approve audited financial results.
- Results are for the half year and financial year ending March 31, 2026.
- Trading window closed from April 1, 2026, until 48 hours post-results declaration.
- Meeting is pursuant to Regulation 29 of SEBI Listing Regulations.
Price Impact
More from GANGAPHARM